Skip to site menu Skip to page content

Daily Newsletter

28 August 2023

Daily Newsletter

28 August 2023

California grants zero-interest loans to 17 community hospitals

Several of the hospitals covered under the initiative are located in rural and lower-income areas, serving communities of colour.

August 25 2023

A total of 17 distressed community hospitals in California, US, have secured interest-free loans from the state government.

As part of this initiative, around $300m in loans will be provided to 17 community hospitals via the Distressed Hospital Loan Program (DHLP).

Several of the hospitals covered under this initiative are located in rural and lower-income areas, serving communities of colour. They have been hit by financial challenges, exacerbated by the Covid-19 pandemic.

The DHLP aims to keep these hospitals operational or reopen recently closed facilities.

This programme is jointly administered by the Department of Health Care Access and Information as well as the California Health Facilities Financing Authority at the state Treasurer’s Office.

The loans are expected to help ensure continued access to healthcare services for Californians, particularly in areas where these hospitals are the only acute healthcare access points available.

Senator Caballero said: “With numerous hospitals on the brink of bankruptcy in California, my number one priority this year has been to ensure that residents of the 14th Senate District had access to high-quality health care.

“I have worked diligently with my legislative colleagues, the Governor and stakeholders to find sustainable solutions and the Distressed Hospital Loan Program became the centrepiece of a larger relief package.

“It brings me tremendous relief to know that Madera Community Hospital and Hazel Hawkins Memorial Hospital in San Benito County have received grant awards and will be able to ensure that people can once again receive services in their own communities.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close